XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity
3 Months Ended
Jul. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stockholders' Equity

9. Stockholders’ Equity

Equity Incentive Awards

As of July 30, 2021, we have certain equity incentive awards (awards) outstanding, which include stock options and restricted stock units (RSUs), including time-based RSUs and performance-based RSUs (PBRSUs). Also outstanding are purchase rights under our Employee Stock Purchase Plan (ESPP).

Stock Options

Less than 1 million options were outstanding as of July 30, 2021 and April 30, 2021. 

Information related to our stock options is summarized below (in millions):

 

 

Three Months Ended

 

 

 

July 30,

2021

 

 

July 31,

2020

 

Intrinsic value of exercises

 

$

5

 

 

$

 

Fair value of options vested

 

$

1

 

 

$

 

Restricted Stock Units

In the three months ended July 30, 2021, we granted PBRSUs to certain of our executives. Each PBRSUs has performance-based vesting criteria, in addition to the service-based vesting criteria, such that the PBRSUs cliff-vest at the end of an approximate one, two or three year performance period, which began on the date specified in the grant agreements and typically ends on the last day of the first, second or third fiscal year, respectively, following the grant date. The number of shares of common stock that will be issued to settle most of these PBRSUs at the end of the performance and service period will range from 0% to 200% of a target number of shares originally granted. For most of the PBRSUs granted in the three months ended July 30, 2021, the number of shares issued will depend upon our Total Stockholder Return (TSR) as compared to the TSR of a specified group of benchmark peer companies (each expressed as a growth rate percentage) calculated as of the end of the performance period. The fair values of these TSR performance-based awards were fixed at grant date using a Monte Carlo simulation model. The aggregate grant date fair value of all PBRSUs granted in the current year was $41 million, which is being recognized to compensation expense over the remaining performance / service periods.

The following table summarizes information related to our RSUs, including PBRSUs, (in millions, except fair value):

 

 

 

Number of

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

Outstanding as of April 30, 2021

 

 

9

 

 

$

47.75

 

Granted

 

 

4

 

 

$

81.15

 

Vested

 

 

(2

)

 

$

48.37

 

Forfeited

 

 

(1

)

 

$

53.83

 

Outstanding as of July 30, 2021

 

 

10

 

 

$

59.95

 

We primarily use the net share settlement approach upon vesting, where a portion of the shares are withheld as settlement of employee withholding taxes, which decreases the shares issued to the employee by a corresponding value. The number and value of the shares netted for employee taxes are summarized in the table below (in millions):

 

 

 

Three Months Ended

 

 

 

July 30,

2021

 

 

July 31,

2020

 

Shares withheld for taxes

 

 

1

 

 

 

1

 

Fair value of shares withheld

 

$

57

 

 

$

33

 

 Employee Stock Purchase Plan

The following table summarizes activity related to the purchase rights issued under the ESPP (in millions):

 

 

 

Three Months Ended

 

 

 

July 30,

2021

 

 

July 31,

2020

 

Shares issued under the ESPP

 

 

1

 

 

 

1

 

Proceeds from issuance of shares

 

$

52

 

 

$

48

 

 

Stock-Based Compensation Expense

Stock-based compensation expense is included in the condensed consolidated statements of income as follows (in millions):

 

 

 

Three Months Ended

 

 

 

July 30,

2021

 

 

July 31,

2020

 

Cost of product revenues

 

$

1

 

 

$

1

 

Cost of services revenues

 

 

2

 

 

 

3

 

Sales and marketing

 

 

26

 

 

 

25

 

Research and development

 

 

16

 

 

 

19

 

General and administrative

 

 

8

 

 

 

6

 

Total stock-based compensation expense

 

$

53

 

 

$

54

 

Income tax benefit for stock-based compensation expense

 

$

5

 

 

$

4

 

As of July 30, 2021, total unrecognized compensation expense related to our equity awards was $567 million, which is expected to be recognized on a straight-line basis over a weighted-average remaining service period of 2.7 years.

Stock Repurchase Program

As of July 30, 2021, our Board of Directors has authorized the repurchase of up to $14.1 billion of our common stock. Under this program, we may purchase shares of our outstanding common stock through solicited or unsolicited transactions in the open market, in privately negotiated transactions, through accelerated share repurchase programs, pursuant to a Rule 10b5-1 plan or in such other manner as deemed appropriate by our management. The stock repurchase program may be suspended or discontinued at any time.

The following table summarized activity related to the stock repurchase program for the three months ended July 30, 2021 (in millions, except for per share amounts):

 

Number of shares repurchased

 

 

1

 

Average price per share

 

$

80.08

 

Stock repurchases allocated to additional paid-in capital

 

$

3

 

Stock repurchases allocated to retained earnings

 

$

97

 

Remaining authorization at end of period

 

$

752

 

Since the May 13, 2003 inception of our stock repurchase program through July 30, 2021, we repurchased a total of 341 million shares of our common stock at an average price of $39.17 per share, for an aggregate purchase price of $13.4 billion.

Dividends

The following is a summary of our activities related to dividends on our common stock (in millions, except per share amounts):

 

 

 

Three Months Ended

 

 

 

July 30,

2021

 

 

July 31,

2020

 

Dividends per share declared

 

$

0.50

 

 

$

0.48

 

Dividend payments allocated to additional paid-in capital

 

$

 

 

$

30

 

Dividend payments allocated to retained earnings

 

$

112

 

 

$

77

 

 

On August 23, 2021, we declared a cash dividend of $0.50 per share of common stock, payable on October 27, 2021 to holders of record as of the close of business on October 8, 2021. The timing and amount of future dividends will depend on market conditions, corporate business and financial considerations and regulatory requirements. All dividends declared have been determined by us to be legally authorized under the laws of the state in which we are incorporated.

 

 

 

 

 

 

 

 

 

 

Accumulated Other Comprehensive Income (Loss)

Changes in accumulated other comprehensive income (loss) (AOCI) by component, net of tax, are summarized below (in millions):

 

 

 

Foreign

Currency

Translation

Adjustments

 

 

Defined

Benefit

Obligation

Adjustments

 

 

Unrealized

Gains

(Losses) on

Available-

for-Sale

Securities

 

 

Unrealized

Gains

(Losses) on

Derivative

Instruments

 

 

Total

 

Balance as of April 30, 2021

 

$

(27

)

 

$

(4

)

 

$

1

 

 

$

 

 

$

(30

)

Other comprehensive income (loss), net of tax

 

 

(4

)

 

 

 

 

 

(1

)

 

 

1

 

 

 

(4

)

Total other comprehensive income (loss)

 

 

(4

)

 

 

 

 

 

(1

)

 

 

1

 

 

 

(4

)

Balance as of July 30, 2021

 

$

(31

)

 

$

(4

)

 

$

 

 

$

1

 

 

$

(34

)

 

 

The amounts reclassified out of AOCI are as follows (in millions):

 

 

 

Three Months Ended

 

 

 

 

 

July 30,

2021

 

 

July 31,

2020

 

 

Statements of

Income Classification

Realized losses on cash flow hedges

 

 

 

 

 

1

 

 

Net revenues

Total reclassifications

 

$

 

 

$

1